Federico Giovanni Rizzo

• Ziel der Thesis ist herauszufinden, ob ein Markteintritt der mybacs GmbH in Schweden sinnvoll ist. Hierfür werden die dabei auftretenden Chancen und Risiken erarbeitet, um erfolgreich als Leitfaden und Entscheidungshilfe für mybacs GmbH zu dienen.
• This bachelor thesis deals with the chances and risks of a market entry of the company mybacs GmbH in Sweden. mybacs is a research oriented DtoC biotechnology company that mainly manufactures intestinal health products in Zug (Switzerland) and Munich (Germany). The company is a network of pharmacists, physicians, innovators and entrepreneurs. The question is investigated how the market entry possibilities in Sweden can be designed. The aim is to clarify to what extent the market in Sweden and the country are interesting, which motives are to be cited for a market entry of mybacs in the Swedish market and how the chances and risks for mybacs in Sweden are designed. Especially considering the pharmaceutical orientation of the company. These aspects will be discussed by evaluating current literature and a final analysis using the practical example of mybacs. The theoretical results clearly show that the decision to enter the market depends mainly on the current political, economic and social situation. Therefore, companies should consider economic, social and political conditions for market entry to limit or avoid the effects of inflation, political risks or trade protectionist measures. Consequently, the choice of market entry form is of great importance. This is also made clear by the final example of mybacs, which consciously decide to export.